Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
0.4118
-0.0108 (-2.56%)
At close: Nov 3, 2025, 4:00 PM EST
0.4118
0.00 (0.00%)
Pre-market: Nov 4, 2025, 8:00 AM EST
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $15.72 million as of November 4, 2025. Its market cap has increased by 12.30% in one year.
Market Cap
15.72M
Enterprise Value
9.14M
1-Year Change
12.30%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since June 12, 2006, Can-Fite BioPharma's market cap has increased from $3.58M to $15.72M, an increase of 339.25%. That is a compound annual growth rate of 7.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 15.72M | 1.05% |
| Dec 31, 2024 | 15.56M | 75.98% |
| Dec 31, 2023 | 8.84M | -54.56% |
| Dec 29, 2022 | 19.46M | -49.59% |
| Dec 30, 2021 | 38.60M | 34.47% |
| Dec 31, 2020 | 28.71M | 121.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 802.74B |
| Johnson & Johnson | 448.76B |
| AbbVie | 374.44B |
| UnitedHealth Group | 302.36B |
| AstraZeneca | 252.04B |
| Novartis AG | 236.44B |
| Novo Nordisk | 216.34B |
| Abbott Laboratories | 215.34B |